GOLDMAN SACHS GROUP INC

Position in IMUX — Immunic, Inc.

CIK 886982 NEW YORK, NY

Position in IMUX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$166,244

+$148,010 QoQ

Shares Held

149,770

+984.2% QoQ

Ownership

1.10%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. IMUX ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$166,244	149,770	+984.2%	Shares	Defined	2026-05-15
2024-03-31	$18,234	13,814	-58.9%	Shares	Defined	2024-05-15
2023-03-31	$50,020	33,571	+135.4%	Shares	Defined	2024-05-14
2022-09-30	$45,071	14,263	-47.0%	Shares	Defined	2024-05-14
2022-06-30	$93,311	26,891	-89.1%	Shares	Defined	2024-05-14
2022-03-31	$2,781,166	246,121	+39.7%	Shares	Defined	2022-05-16
2021-12-31	$1,685,449	176,118	+4.9%	Shares	Defined	2022-02-17
2021-09-30	$1,485,711	167,877	+1283.9%	Shares	Defined	2022-01-20
2021-06-30	$148,726	12,131	-46.7%	Shares	Defined	2021-08-13
2020-12-31	$347,709	22,741	+4.9%	Shares	Defined	2021-02-12
2020-09-30	$402,393	21,669	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.